Identification of N-acyl 4-(3-pyridonyl)phenylalanine derivatives and their orally active prodrug esters as dual acting α4β1 and α4β7 receptor antagonists
Authors:
- Jefferson W. TilleyJTJefferson W. Tilley
- Achyutharao SidduriASAchyutharao Sidduri
- Jianping LouJLJianping Lou
- Gerry KaplanGKGerry Kaplan
- Nadine TareNTNadine Tare
- Gary CavalloGCGary Cavallo
- Karl FrankKFKarl Frank
- Anjula PamidimukkalaAPAnjula Pamidimukkala
- Duk Soon ChoiDCDuk Soon Choi
- Louise GerberLGLouise Gerber
- Aruna RailkarARAruna Railkar
- Louis RenzettiLRLouis Renzetti
- 1 February 2013
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 23 (4) , 1036-1040
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Firategrast for relapsing remitting multiple sclerosis: a phase 2, randomised, double-blind, placebo-controlled trialThe Lancet Neurology, 2012
- Very late antigen-4 integrin antagonistsExpert Opinion on Therapeutic Patents, 2008
- Synthesis and SAR of pyridazinone-substituted phenylalanine amide α4 integrin antagonistsBioorganic & Medicinal Chemistry Letters, 2008
- Alpha4-integrin antagonism — an effective approach for the treatment of inflammatory diseases?Drug Discovery Today, 2007
- Natalizumab and the role of α4-integrin antagonism in the treatment of multiple sclerosisExpert Opinion on Biological Therapy, 2006
- Integrins as targets in therapyExpert Opinion on Therapeutic Patents, 2006
- Synthesis and Biological Evaluation of Novel Pyridazinone-Based α4Integrin Receptor AntagonistsJournal of Medicinal Chemistry, 2006
- Blocking adhesion molecules as therapy for multiple sclerosis: natalizumabNature Reviews Drug Discovery, 2005
- Natalizumab for Active Crohn's DiseaseNew England Journal of Medicine, 2003
- Synthesis and SAR of N-Benzoyl-?-Biphenylalanine Derivatives: Discovery of TR-14035, A Dual α4β7/α4β1 Integrin AntagonistBioorganic & Medicinal Chemistry, 2002